靶向DEC-205递送M2e诱导增强的血清抗体依赖性异亚型流感保护
该研究将流感A病毒M2e肽化学交联至抗DEC-205单抗,联合poly I:C佐剂皮下免疫BALB/c小鼠三次。结果显示该偶联物诱导高水平血清抗体,并对异亚型IAV致死攻击提供高达76%的保护,且保护依赖非中和血清抗体、不依赖效应CD4+ T细胞。
要点
- α-DEC-205:M2e偶联物联合poly I:C三次皮下免疫可诱导高水平血清抗体。
- 该免疫对异亚型IAV致死攻击提供高达76%保护,高于对照的20%至40%。
- 保护依赖非中和血清抗体,不依赖效应CD4+ T细胞。
核心结论
- 将M2e靶向DEC-205是诱导强异亚型流感保护的有效替代策略。
研究设计与样本
- BALB/c小鼠皮下接种三次,每次偶联物相当于1 µg M2e,联合poly I:C佐剂。
- 对照包括同型对照mAb交联M2e、5 µg游离M2e肽、α-DEC-205:OVA及单用poly I:C。
主要发现
- α-DEC-205:M2e诱导的血清抗体水平高于同型对照:M2e或游离M2e肽,且IgG1均占优势。
- α-DEC-205:M2e未预防发病,但对异亚型IAV致死攻击诱导高达76%保护。
- 同型对照:M2e或游离M2e肽诱导20%至40%保护。
- 保护依赖非中和血清抗体,独立于效应CD4+ T细胞。
关键数值与推荐
- α-DEC-205:M2e组对异亚型IAV致死攻击保护率达76%。
- 同型对照:M2e或游离M2e肽组保护率为20%至40%。
临床怎么用
- 提示靶向DC的DEC-205受体可增强M2e疫苗候选的体液免疫与异亚型保护。
- 非中和血清抗体可作为M2e疫苗保护评价的参考指标。
局限性
- 研究仅在小鼠模型中进行,尚未在人体验证。
- 原文未报告保护持久性及更长期免疫记忆数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The ectodomain of the influenza A virus (IAV) M2 protein (M2e) is highly conserved, and it represents a promising candidate for the development of an "universal vaccine". However, the low immunogenicity associated to M2e in a natural infection or in response to seasonal vaccines has led to explore new approaches to enhance it. In recent years, it has become clear that targeting antigens to dendritic cells (DC) is an efficient way to enhance immune responses against pathogens. In this work, the M2e peptide was chemically cross-linked to a monoclonal antibody (mAb) specific for DEC-205 (α-DEC-205:M2e), present on DC. BALB/c mice were inoculated subcutaneously (s.c.) three times with the conjugate equivalent to 1 µg of M2e, in the presence of polyinosinic-polycytidylic acid (poly I:C) as adjuvant. As controls, other groups of mice were inoculated under the same conditions with M2e cross-linked to an isotype control mAb (isotype:M2e), 5 µg of free M2e peptide, ovalbumin (OVA) cross-linked to the α-DEC-205 mAb (α-DEC-205:OVA) or poly I:C alone. Immunization with α-DEC-205-M2e induced high levels of serum antibodies (Abs) compared to isotype:M2e or to free M2e peptide, and in all cases IgG1 was predominant over IgG2a Abs. Furthermore, immunization with the α-DEC-205:M2e conjugate did not prevent morbidity, but it induced up to 76% protection against a heterosubtypic IAV lethal challenge. Contrasting with the 20 to 40% protection induced by isotype:M2e or by free M2e peptide. The protection induced by α-DEC-205:M2e conjugate was dependent on non-neutralizing serum Abs and independent of effector CD4+ T cells. These results show that targeting M2e to DEC-205 is a very effective alternative to induce strong heterosubtypic protection against an IAV infection.
引用
- Padilla-Quirarte HO, Badillo-Godinez O, Gutierrez-Xicotencatl L, et al. Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection. Vaccine. 2019. PMID: 30955979. doi:10.1016/j.vaccine.2019.02.050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。